where are the phase 2 hrv clinical results, page-3

I smell a rat... perhaps it's a takeover after all. Agreed 4 weeks isn't much but it's a small trial and it was completed a long while back. The time to compile data shouldn't take longer than the Phase III LANI study. The results should be quite clear cut... either the drug prevents you getting the cold or it doesn't.

There are very exciting times ahead for BTA, I hope there is no takeover or bad trial news. Organic growth is the best long term addition of value to shareholders. BTA has a good pipeline and cash to fund them.

We are also due to hear something about RSV, a move to phase II should trigger another milestone payment which would also be most welcome.

LANI - If DS are looking to distribute it themselves then this will impact BTA big time. It then comes down to their negotiating abilities... if they want to stay in the game they'll have to raise capital. Time to list on the Nasdaq Directors!!
Have a look

http://finance.yahoo.com/echarts?s=BCRX#chart1:symbol=bcrx;range=3m;indicator=volume;charttype=line;crosshair=on;ohlcvalues=0;logscale=on;source=undefined

BCRX are above the "swine flu" high... and had some poor results on peramivir.